https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-01-23 / Int. J. Oncol. 2015 Apr;46(4):1699-709
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-01-23 / Int. J. Oncol. 2015 Apr;46(4):1699-7092015-01-23 00:00:002019-02-15 08:52:05Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2240-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2240-22010-11-01 00:00:002019-02-15 08:52:01[WT1 peptide pulsed dendritic cell therapy with activated T lymphocytes therapy for advanced cancers]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-14 / Cancer Sci. 2009 Aug;100(8):1502-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-14 / Cancer Sci. 2009 Aug;100(8):1502-92009-05-14 00:00:002019-02-15 08:52:02Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-242008-08-12 00:00:002019-02-15 08:52:02Novel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-52007-12-01 00:00:002007-12-01 00:00:00Experimental evidence for the efficacy of combined therapy of CPT-11 and hyperthermia for squamous cell carcinoma of the esophagus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-18 / Vaccine 2005 Nov;23(45):5225-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-18 / Vaccine 2005 Nov;23(45):5225-302005-08-18 00:00:002005-08-18 00:00:00Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-59
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-592004-09-01 00:00:002004-09-01 00:00:00A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-10-01 / J. Hematother. Stem Cell Res. 2003 Oct;12(5):515-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-10-01 / J. Hematother. Stem Cell Res. 2003 Oct;12(5):515-232003-10-01 00:00:002003-10-01 00:00:00Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-802002-04-01 00:00:002002-04-01 00:00:00[Immunotherapy for esophageal carcinoma]
